Skip to main content
Atrás
Watch Compare

INTERPACE BIOSCIENCES, INC.

Calidad de datos: 100%
IDXG
OTC Manufacturing Measuring & Analyzing Instruments
$2.30
▲ $0.31 (15.29%)
Cap. Mercado: 63.71 M
Precio
$2.30
Cap. Mercado
63.71 M
Rango del Día
$2.00 — $2.38
Rango de 52 Semanas
$0.44 — $2.38
Volumen
4,774
Apertura $2.00
Promedio 50D / 200D
$1.78
29.57% above
Promedio 50D / 200D
$1.17
96.40% above

Quick Summary

Puntos Clave

Revenue declined -1.60% annually over 5 years
Earnings grew 266.68% over the past year
Net margin of 63.46% shows strong profitability
Generating 5.48 M in free cash flow
P/E of 2.59 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 15.87%

Crecimiento

Revenue Growth (5Y)
-1.60%
Below sector avg (1.82%)
Revenue (1Y)-17.47%
Earnings (1Y)266.68%
FCF Growth (3Y)28.44%

Calidad

Return on Equity
N/A
ROIC72.43%
Net Margin63.46%
Op. Margin10.55%

Seguridad

Debt / Equity
N/A
Current Ratio1.54
Interest CoverageN/A

Valoración

PE (TTM)
2.59
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDA13.66
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E 2.6 -1.5
P/B — 1.6
ROE % — -53.4
Net Margin % 63.5 -41.5
Rev Growth 5Y % -1.6 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -17.47% Revenue Growth (3Y) -1.87%
Earnings Growth (1Y) 266.68% Earnings Growth (3Y) 453.55%
Revenue Growth (5Y) -1.60% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 38.73 M Net Income (TTM) 24.58 M
ROE N/A ROA 201.67%
Gross Margin 62.31% Operating Margin 10.55%
Net Margin 63.46% Free Cash Flow (TTM) 5.48 M
ROIC 72.43% FCF Growth (3Y) 28.44%
Safety
Debt / Equity N/A Current Ratio 1.54
Interest Coverage N/A Asset Turnover 3.18
Working Capital 3.19 M Tangible Book Value -298,000
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 2.59 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1.65
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 13.66 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 8.59%
Market Cap 63.71 M Enterprise Value 61.61 M
Per Share
EPS (Diluted TTM) 0.89 Revenue / Share 1.40
FCF / Share 0.20 OCF / Share 0.21
EPS CAGR (1Y) 122.50% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.92% FCF Conversion 22.28%
SBC-Adj. FCF 5.36 M Growth Momentum -15.87

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 38.73 M 46.93 M 40.21 M 5.68 M 41.31 M
Net Income 24.58 M 6.70 M 802,000.0 -21.96 M -14.94 M
EPS (Diluted) 0.89 0.40 0.18 — —
Gross Profit 24.13 M 29.93 M 23.90 M 18.23 M 17.95 M
Operating Income 4.08 M 8.11 M 2.80 M -3.62 M -14.00 M
EBITDA — — — — —
R&D Expenses 642,000.0 676,000.0 636,000.0 703,000.0 1.88 M
SG&A Expenses — — — — —
D&A 425,000.0 300,000.0 1.03 M 2.56 M 5.37 M
Interest Expense — -34,000.0 -112,000.0 -158,000.0 —
Income Tax -21.21 M 4,000.0 17,000.0 29,000.0 -667,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 33.84 M 14.79 M 13.02 M 15.98 M 38.43 M
Total Liabilities 11.48 M 17.01 M 28.16 M 32.52 M 34.31 M
Shareholders' Equity 22.36 M -2.22 M -61.67 M -63.07 M -42.42 M
Total Debt — — — — —
Cash & Equivalents 2.51 M 1.46 M 3.50 M 4.83 M 3.06 M
Current Assets 9.90 M 11.77 M 10.32 M 12.15 M 12.17 M
Current Liabilities 5.10 M 10.62 M 17.47 M 14.28 M 15.68 M